Trinity Biotech Operating Margin 2010-2024 | TRIB
Current and historical operating margin for Trinity Biotech (TRIB) over the last 10 years. The current operating profit margin for Trinity Biotech as of March 31, 2024 is -40.17%.
| Trinity Biotech Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-03-31 | $0.06B | $-0.03B | -47.37% |
| 2023-12-31 | $0.06B | $-0.03B | -49.12% |
| 2023-09-30 | $0.06B | $-0.03B | -53.33% |
| 2023-06-30 | $0.06B | $-0.04B | -57.38% |
| 2023-03-31 | $0.06B | $-0.02B | -35.48% |
| 2022-12-31 | $0.06B | $-0.02B | -30.16% |
| 2022-09-30 | $0.07B | $-0.01B | -14.93% |
| 2022-06-30 | $0.07B | $0.00B | 1.37% |
| 2022-03-31 | $0.08B | $0.00B | 3.57% |
| 2021-12-31 | $0.09B | $0.01B | 7.45% |
| 2021-09-30 | $0.11B | $-0.01B | -4.67% |
| 2021-06-30 | $0.12B | $0.00B | 0.85% |
| 2021-03-31 | $0.11B | $0.00B | 1.87% |
| 2020-12-31 | $0.10B | $0.00B | 0.98% |
| 2020-09-30 | $0.09B | $-0.02B | -17.78% |
| 2020-06-30 | $0.08B | $-0.02B | -28.92% |
| 2020-03-31 | $0.09B | $-0.02B | -26.97% |
| 2019-12-31 | $0.09B | $-0.03B | -27.78% |
| 2019-09-30 | $0.09B | $-0.02B | -23.40% |
| 2019-06-30 | $0.09B | $-0.02B | -23.66% |
| 2019-03-31 | $0.10B | $-0.02B | -21.88% |
| 2018-12-31 | $0.10B | $-0.02B | -20.41% |
| 2018-09-30 | $0.10B | $-0.04B | -37.76% |
| 2018-06-30 | $0.10B | $-0.04B | -36.00% |
| 2018-03-31 | $0.10B | $-0.04B | -36.00% |
| 2017-12-31 | $0.10B | $-0.04B | -37.00% |
| 2017-09-30 | $0.10B | $-0.04B | -42.42% |
| 2017-06-30 | $0.10B | $-0.04B | -41.41% |
| 2017-03-31 | $0.10B | $-0.04B | -41.00% |
| 2016-12-31 | $0.10B | $-0.04B | -40.00% |
| 2016-09-30 | $0.10B | $0.01B | 9.90% |
| 2016-06-30 | $0.10B | $0.01B | 9.90% |
| 2016-03-31 | $0.10B | $0.01B | 11.11% |
| 2015-12-31 | $0.10B | $0.01B | 13.00% |
| 2015-09-30 | $0.10B | $0.01B | 10.78% |
| 2015-06-30 | $0.10B | $0.01B | 12.62% |
| 2015-03-31 | $0.11B | $0.02B | 14.29% |
| 2014-12-31 | $0.11B | $0.02B | 15.24% |
| 2014-09-30 | $0.10B | $0.01B | 10.68% |
| 2014-06-30 | $0.10B | $0.01B | 11.00% |
| 2014-03-31 | $0.10B | $0.01B | 10.53% |
| 2013-12-31 | $0.09B | $0.01B | 10.00% |
| 2013-09-30 | $0.09B | $0.02B | 19.77% |
| 2013-06-30 | $0.08B | $0.02B | 19.28% |
| 2013-03-31 | $0.08B | $0.02B | 19.28% |
| 2012-12-31 | $0.08B | $0.02B | 19.28% |
| 2012-09-30 | $0.08B | $0.02B | 20.73% |
| 2012-06-30 | $0.08B | $0.02B | 20.99% |
| 2012-03-31 | $0.08B | $0.02B | 21.52% |
| 2011-12-31 | $0.08B | $0.02B | 20.51% |
| 2011-09-30 | $0.08B | $0.01B | 18.18% |
| 2011-06-30 | $0.08B | $0.01B | 17.11% |
| 2011-03-31 | $0.08B | $0.01B | 16.25% |
| 2010-12-31 | $0.09B | $0.01B | 15.56% |
| 2010-09-30 | $0.10B | $0.01B | 13.73% |
| 2010-06-30 | $0.12B | $0.02B | 13.04% |
| 2010-03-31 | $0.12B | $0.02B | 12.10% |
| 2009-12-31 | $0.13B | $0.01B | 11.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.016B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.017B | 23.31 |
| Stryker (SYK) | United States | $126.483B | 30.29 |
| Boston Scientific (BSX) | United States | $111.661B | 35.56 |
| EssilorLuxottica (ESLOY) | France | $99.732B | 0.00 |
| Medtronic (MDT) | Ireland | $98.953B | 14.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.630B | 28.20 |
| ResMed (RMD) | United States | $27.824B | 26.12 |
| Terumo (TRUMY) | Japan | $24.790B | 35.01 |
| Koninklijke Philips (PHG) | Netherlands | $23.594B | 18.73 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.927B | 14.01 |
| Baxter (BAX) | United States | $16.898B | 12.01 |
| Insulet (PODD) | United States | $13.778B | 61.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.986B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.709B | 36.26 |
| Bio-Rad Laboratories (BIO) | United States | $7.704B | 25.19 |
| Lantheus Holdings (LNTH) | United States | $5.515B | 13.74 |
| Haemonetics (HAE) | United States | $4.287B | 21.14 |
| GN Store Nord (GNNDY) | Denmark | $4.205B | 23.62 |
| Perrigo (PRGO) | Ireland | $3.570B | 10.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.360B | 15.99 |
| Neogen (NEOG) | United States | $3.295B | 31.69 |
| TG Therapeutics (TGTX) | United States | $2.904B | 81.70 |
| ICU Medical (ICUI) | United States | $2.875B | 25.37 |
| Envista Holdings (NVST) | United States | $2.800B | 11.55 |
| Green Thumb Industries (GTBIF) | United States | $2.467B | 48.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.386B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.077B | 11.53 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 53.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.761B | 0.00 |
| Warby Parker (WRBY) | United States | $1.609B | 0.00 |
| InMode (INMD) | Israel | $1.468B | 7.80 |
| Verano Holdings (VRNOF) | United States | $1.292B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.292B | 9.60 |
| AtriCure (ATRC) | United States | $1.068B | 0.00 |
| Owens & Minor (OMI) | United States | $1.003B | 8.74 |
| National Vision Holdings (EYE) | United States | $0.977B | 31.08 |
| BioLife Solutions (BLFS) | United States | $0.923B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.694B | 14.78 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| PetIQ (PETQ) | United States | $0.672B | 21.73 |
| Surmodics (SRDX) | United States | $0.599B | 37.48 |
| VAREX IMAGING (VREX) | United States | $0.587B | 13.81 |
| ZimVie (ZIMV) | United States | $0.506B | 43.16 |
| Valneva SE (VALN) | France | $0.501B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.495B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| Biote (BTMD) | United States | $0.459B | 10.57 |
| Jin Medical (ZJYL) | China | $0.438B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.298B | 9.60 |
| Zynex (ZYXI) | United States | $0.283B | 38.78 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.256B | 25.39 |
| Sanara MedTech (SMTI) | United States | $0.238B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.234B | 14.75 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.165B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 19.89 |
| Veru (VERU) | United States | $0.134B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 10.29 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.097B | 16.31 |
| Cellectar Biosciences (CLRB) | United States | $0.089B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.071B | 4.66 |
| MariMed (MRMD) | United States | $0.071B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.97 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |